NJ A1646 | 2024-2025 | Regular Session
Note: Carry Over of previous A3245
Note: Carry Over of previous S323
Note: Carry Over of previous S323
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 9 2024 - 25% progression
Action: 2024-01-09 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 9 2024 - 25% progression
Action: 2024-01-09 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
Title
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-01-09 | Assembly | Introduced, Referred to Assembly Financial Institutions and Insurance Committee |
Same As/Similar To
A3245 (Carry Over) 2022-03-07 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
S323 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S323 (Carry Over) 2022-01-11 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Subjects
New Jersey State Sources
Type | Source |
---|---|
Summary | https://www.njleg.state.nj.us/bill-search/2024/A1646 |
Text | https://pub.njleg.gov/Bills/2024/A2000/1646_I1.HTM |